Overview

Red wine contains polyphenols — including resveratrol, proanthocyanidins (tannins), quercetin, and anthocyanins — extracted from grape skins during fermentation. It is also, fundamentally, an alcoholic beverage, and its health reputation is more complicated and more contested than popular coverage often suggests. This page aims to present a balanced view rather than promote alcohol consumption for health.

The “French Paradox” and what happened to it

In the late 1980s and 1990s, researchers noted that France had comparatively low rates of coronary heart disease despite a diet high in saturated fat, and moderate red wine consumption was proposed as a possible explanation — the “French Paradox.” Subsequent research complicated this picture considerably: differences in overall diet pattern, smoking trends, healthcare reporting, and other lifestyle factors likely explain much of the gap, and the wine-specific effect, if any, appears small. Much of the original observational data on “moderate drinkers” also suffered from a well-documented confound: comparison groups of “abstainers” often included former heavy drinkers and people who quit due to illness, which can make moderate drinking look artificially protective. More recent, better-controlled analyses (including Mendelian randomization studies, which reduce this kind of confounding) generally do not support a protective causal effect of alcohol on health.

Resveratrol: promising in mice, unproven at wine-drinking doses in humans

Resveratrol has shown effects on aging and metabolic pathways in animal and cell studies, but the doses used are far beyond what’s achievable through wine — commonly cited estimates suggest reaching those animal-study doses through wine alone would require an implausible number of bottles per day. Resveratrol also has poor oral bioavailability. Human trials of resveratrol supplements have not produced the dramatic benefits seen in mice.

Current public health guidance on alcohol, including wine

Guidance has shifted in recent years toward more caution. The U.S. Dietary Guidelines for Americans note that even moderate drinking is associated with increased risk of certain health harms, including several cancers, and recommend that people who don’t currently drink not start for health benefits. In January 2023, the World Health Organization stated that no level of alcohol consumption can be considered safe for health, given established links between alcohol and cancer risk (including breast and colorectal cancer) that appear to increase even at low intake levels. The U.S. Surgeon General also issued an advisory in 2025 highlighting alcohol’s contribution to cancer risk. This represents a real and significant shift from the older “moderate drinking may protect the heart” framing.

Safety and contraindications

No safe amount for some groups: Pregnant individuals, people with a personal or family history of alcohol use disorder, people taking interacting medications, and people with certain liver, pancreatic, or cardiac conditions should not drink alcohol, including wine.
Cancer risk: Alcohol is a Group 1 carcinogen (IARC classification); risk appears to rise with the amount consumed, without a clearly established “zero-risk” threshold.
Interactions: Alcohol interacts with many medications, including sedatives, some antidepressants, and metronidazole, among others.

Bottom line

If you already drink and choose to include wine, current guidance frames that as a personal choice with known trade-offs rather than a health intervention — red wine’s modest polyphenol content does not offset alcohol’s risks, and non-alcoholic sources of the same polyphenols (grapes, berries, tea) are available without the alcohol-related risk profile.

Sources

Clinically reviewed by Dr. Shilpa Thakur. Last reviewed 2026-07-20. Educational information, not medical advice; if you drink alcohol, or are considering whether to, discuss your personal risk factors with a qualified clinician.

Red Wine: Resveratrol, Polyphenols & the French Paradox Revisited